Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Carmustine poisoning |
Causative agent (attribute) |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Accidental carmustine poisoning |
Causative agent (attribute) |
False |
Carmustine (substance) |
Inferred relationship |
Some |
|
Intentional carmustine poisoning |
Causative agent (attribute) |
False |
Carmustine (substance) |
Inferred relationship |
Some |
|
intoxication par la carmustine d'intention indéterminée |
Causative agent (attribute) |
False |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Carmustine adverse reaction |
Causative agent (attribute) |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Allergy to carmustine |
Causative agent (attribute) |
False |
Carmustine (substance) |
Inferred relationship |
Some |
|
Carmustine overdose |
Causative agent (attribute) |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Accidental carmustine overdose |
Causative agent (attribute) |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Intentional carmustine overdose |
Causative agent (attribute) |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
surdose de carmustine d'intention indéterminée |
Causative agent (attribute) |
False |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Carmustine 100mg powder and solvent for infusion vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmustine (substance) |
Inferred relationship |
Some |
|
Carmustine 100mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmustine (substance) |
Inferred relationship |
Some |
|
Carmustine 7.7mg wafer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmustine (substance) |
Inferred relationship |
Some |
|
Product containing carmustine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Carmustine 100mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmustine (substance) |
Inferred relationship |
Some |
|
Carmustine 100mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmustine (substance) |
Inferred relationship |
Some |
|
Accidental carmustine poisoning |
Causative agent (attribute) |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Intentional carmustine poisoning |
Causative agent (attribute) |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Implantation of carmustine wafer into cerebrum (procedure) |
Direct substance |
False |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Implantation of carmustine wafer into cerebrum (procedure) |
Direct substance |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Allergy to carmustine |
Causative agent (attribute) |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Product containing carmustine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Product containing only carmustine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Carmustine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Product containing only carmustine in prolonged-release intralesional implant (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Product containing carmustine in prolonged-release intralesional implant (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Carmustine 100 mg powder for solution for infusion and/or injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Carmustine 100 mg powder for solution for infusion and/or injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Carmustine 100 mg powder for solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |
Carmustine 100 mg powder for solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carmustine (substance) |
Inferred relationship |
Some |
1 |